MiR-139-5p Inhibits the Development of Gastric Cancer through Targeting TPD52

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• MicroRNAs (miRNAs) play a role in gastric cancer (GC) development.
• This study investigates the specific role of miR-139-5p in GC pathogenesis.

Purpose of the Study:

• To elucidate the function of miR-139-5p in gastric cancer.
• To identify the molecular mechanism underlying miR-139-5p's action in GC.

Main Methods:

• Quantitative real-time PCR (qRT-PCR) and western blot were used to assess miR-139-5p and TPD52 expression.
• Functional assays including luciferase reporter, Transwell, and MTT assays were performed.
• TPD52 silencing and overexpression experiments were conducted.

Main Results:

• miR-139-5p was downregulated, while TPD52 was upregulated in GC tissues.
• Reduced miR-139-5p expression correlated with adverse clinical features and poor prognosis.
• Overexpression of miR-139-5p suppressed GC cell proliferation and metastasis.
• miR-139-5p directly targeted TPD52, and TPD52 silencing inhibited GC progression.
• TPD52 upregulation diminished the anti-tumor effects of miR-139-5p.

Conclusions:

• miR-139-5p functions as a tumor suppressor in gastric cancer.
• The miR-139-5p/TPD52 axis is a critical regulator of GC cell proliferation and metastasis.